Author:
Yamasaki Seiji,Kan Norimichi,Harada Takehisa,Ichinose You,Moriguchi Yoshio,Li Li,Sugie Tomoharu,Kodama Hiroshi,Satoh Kohei,Ohgaki Kazuhisa
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Clark GM, Sledge GW, Osborne CK, McGuire WL: Survival from first recurrence: Relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 5: 55?61, 1987
2. Okino T, Kan N, Nakanishi M, Satoh K, Mise K, Teramura Y, Yamasaki S, Hori T, Kodama H, Ohgaki K, Tobe T: The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer. J Cancer Res Clin Oncol 116: 197?202, 1990
3. Yamasaki S, Okino T, Kan N, Satoh K, Mise K, Teramura Y, Harada T, Kodama H, Hori T, Ohgaki K, Tobe T: Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy. J Cancer Res Clin Oncol 118: 157?162, 1992
4. Okamoto H, Minami M, Shoin S, Koshimura S, Shimizu R: Experimental anticancer studies, part XXXI. On the streptococcal preparation having potent anticancer activity. Jpn J Exp Med 36: 175?186, 1966
5. Talmadge JE, Herberman RB: The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treat Rep 70: 171?182, 1986
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献